Cannabis Incannex partners with Curia to accelerate production of IHL-216A New inhalable drug containing CBD designed for efficacious treatment of brain injuries Rowan DunneAugust 2, 2022
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Analysis Texas Original reveals data showcasing popularity of medical cannabis New survey outlines that Texans prefer cannainoid treatment for chronic pain over opioids Rowan DunneJuly 28, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Cannabis Sisters of the Valley launch new CBD Plus product line New extracts offered by the group said to contain raw cannabinoids with 'magical healing powers' Rowan DunneJuly 27, 2022
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Cannabis NuLeaf Naturals implements substantial price reduction on its products CBD producer initiates new customer savings initiative to promote cannabinoid access for the masses Rowan DunneJuly 26, 2022
Cannabis Vapor Cartridge Technology reveals noteworthy new patents Novel extraction method and precise extract dosing gadget said to become game changers for cannabis industry Rowan DunneJuly 26, 2022
Cannabis Green Scientific unveils new lab management system Multi-service provider for cannabis testing introduces new streamlined software for industry Rowan DunneJuly 25, 2022
Psychedelics Field Trip administers new synthetic molecule in Australia Initial dose of FT-104 given in Adelaide, company announces name change Rowan DunneJuly 22, 2022